290 related articles for article (PubMed ID: 10852463)
1. Reduced pancreatic B cell compensation to the insulin resistance of aging: impact on proinsulin and insulin levels.
Røder ME; Schwartz RS; Prigeon RL; Kahn SE
J Clin Endocrinol Metab; 2000 Jun; 85(6):2275-80. PubMed ID: 10852463
[TBL] [Abstract][Full Text] [Related]
2. Disproportionately elevated proinsulin levels reflect the degree of impaired B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus.
Røder ME; Porte D; Schwartz RS; Kahn SE
J Clin Endocrinol Metab; 1998 Feb; 83(2):604-8. PubMed ID: 9467581
[TBL] [Abstract][Full Text] [Related]
3. Effect of sulfonylurea withdrawal on proinsulin levels, B cell function, and glucose disposal in subjects with noninsulin-dependent diabetes mellitus.
Prigeon RL; Jacobson RK; Porte D; Kahn SE
J Clin Endocrinol Metab; 1996 Sep; 81(9):3295-8. PubMed ID: 8784086
[TBL] [Abstract][Full Text] [Related]
4. Release of incompletely processed proinsulin is the cause of the disproportionate proinsulinemia of NIDDM.
Kahn SE; Halban PA
Diabetes; 1997 Nov; 46(11):1725-32. PubMed ID: 9356018
[TBL] [Abstract][Full Text] [Related]
5. Exercise training delineates the importance of B-cell dysfunction to the glucose intolerance of human aging.
Kahn SE; Larson VG; Schwartz RS; Beard JC; Cain KC; Fellingham GW; Stratton JR; Cerqueira MD; Abrass IB
J Clin Endocrinol Metab; 1992 Jun; 74(6):1336-42. PubMed ID: 1592879
[TBL] [Abstract][Full Text] [Related]
6. Disproportionately elevated proinsulin in Pima Indians with noninsulin-dependent diabetes mellitus.
Saad MF; Kahn SE; Nelson RG; Pettitt DJ; Knowler WC; Schwartz MW; Kowalyk S; Bennett PH; Porte D
J Clin Endocrinol Metab; 1990 May; 70(5):1247-53. PubMed ID: 2186054
[TBL] [Abstract][Full Text] [Related]
7. Effect of troglitazone on B cell function, insulin sensitivity, and glycemic control in subjects with type 2 diabetes mellitus.
Prigeon RL; Kahn SE; Porte D
J Clin Endocrinol Metab; 1998 Mar; 83(3):819-23. PubMed ID: 9506734
[TBL] [Abstract][Full Text] [Related]
8. Increased secretion of 32,33 split proinsulin after intravenous glucose in glucose-tolerant first-degree relatives of patients with non-insulin dependent diabetes of European, but not Asian, origin.
Gelding SV; Andres C; Niththyananthan R; Gray IP; Mather H; Johnston DG
Clin Endocrinol (Oxf); 1995 Mar; 42(3):255-64. PubMed ID: 7758230
[TBL] [Abstract][Full Text] [Related]
9. Proinsulin in pregnant women with normal glucose tolerance or mild gestational diabetes mellitus.
Festa A; Shnawa N; Schernthaner G; Haffner SM
Exp Clin Endocrinol Diabetes; 1999; 107(7):447-52. PubMed ID: 10595596
[TBL] [Abstract][Full Text] [Related]
10. Human aging is associated with parallel reductions in insulin and amylin release.
Dechenes CJ; Verchere CB; Andrikopoulos S; Kahn SE
Am J Physiol; 1998 Nov; 275(5):E785-91. PubMed ID: 9814997
[TBL] [Abstract][Full Text] [Related]
11. Effect of insulin resistance and hyperglycemia on proinsulin release in a primate model of diabetes mellitus.
Kahn SE; McCulloch DK; Schwartz MW; Palmer JP; Porte D
J Clin Endocrinol Metab; 1992 Jan; 74(1):192-7. PubMed ID: 1727820
[TBL] [Abstract][Full Text] [Related]
12. Effect of glucocorticoid and growth hormone treatment on proinsulin levels in humans.
Kahn SE; Horber FF; Prigeon RL; Haymond MW; Porte D
Diabetes; 1993 Jul; 42(7):1082-5. PubMed ID: 8513975
[TBL] [Abstract][Full Text] [Related]
13. Elevated plasma proinsulin/insulin ratio is a marker of reduced insulin secretory capacity in healthy young men.
Choi CS; Kim CH; Lee WJ; Park JY; Hong SK; Lee KU
Horm Metab Res; 1999 Apr; 31(4):267-70. PubMed ID: 10333082
[TBL] [Abstract][Full Text] [Related]
14. Diet-induced weight loss is associated with an improvement in beta-cell function in older men.
Utzschneider KM; Carr DB; Barsness SM; Kahn SE; Schwartz RS
J Clin Endocrinol Metab; 2004 Jun; 89(6):2704-10. PubMed ID: 15181045
[TBL] [Abstract][Full Text] [Related]
15. Evidence against a rate-limiting role of proinsulin processing for maximal insulin secretion in subjects with impaired glucose tolerance and beta-cell dysfunction.
Stumvoll M; Fritsche A; Stefan N; Hardt E; Häring H
J Clin Endocrinol Metab; 2001 Mar; 86(3):1235-9. PubMed ID: 11238514
[TBL] [Abstract][Full Text] [Related]
16. [Evaluation of islet beta cell function in subjects with normal glucose tolerance, impaired glucose regulation, and type 2 diabetes mellitus].
Liu J; Li YB; Shao H; Li YX; Yuan YH; Xiao YB; Weng JP
Zhonghua Yi Xue Za Zhi; 2007 May; 87(18):1252-5. PubMed ID: 17686259
[TBL] [Abstract][Full Text] [Related]
17. Insulin deficiency rather than hyperinsulinaemia in newly diagnosed type 2 diabetes mellitus.
Davies MJ; Metcalfe J; Gray IP; Day JL; Hales CN
Diabet Med; 1993 May; 10(4):305-12. PubMed ID: 8508611
[TBL] [Abstract][Full Text] [Related]
18. [Characteristics of dysfunction of islet beta-cell in newly diagnosed type 2 diabetic patients].
Li YB; Zhu DL; Tian HM; Shi LX; Luo ZJ; Yan L; Zeng LY; Zhou ZG; Yang LY; Liu J; Li M; Weng JP
Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(36):2537-41. PubMed ID: 17198561
[TBL] [Abstract][Full Text] [Related]
19. Effects of dexamethasone on glucose-induced insulin and proinsulin release in low and high insulin responders.
Grill V; Pigon J; Hartling SG; Binder C; Efendic S
Metabolism; 1990 Mar; 39(3):251-8. PubMed ID: 2407926
[TBL] [Abstract][Full Text] [Related]
20. Is the defect in pro-hormone processing in Type 2 diabetes mellitus restricted to the beta cell?
Bano G; Rodin DA; White A; O'Rahilly S; Nussey SS
Diabet Med; 2001 Jan; 18(1):17-21. PubMed ID: 11168336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
